VILOBELIMAB

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Possibly Marketed Outside US

Approval Year

Name

Type

Language

VILOBELIMAB

Official Name

English

IMMUNOGLOBULIN G4, ANTI-(HUMAN COMPLEMENT C5A) (HUMAN-MUS MUSCULUS MONOCLONAL IFX-1 .GAMMA.4-CHAIN), DISULFIDE WITH HUMAN-MUS MUSCULUS MONOCLONAL IFX-1 .KAPPA.-CHAIN, DIMER

Systematic Name

English

CACP29

Code

English

vilobelimab [INN]

Common Name

English

Vilobelimab [WHO-DD]

Common Name

English

IFX-1

Code

English

VILOBELIMAB [USAN]

Common Name

English

CACP 29

Code

English

IMMUNOGLOBULIN G4-KAPPA, ANTI-(HOMO SAPIENS C5 (COMPLEMENT 5) ANAPHYLATOXIN (C5A, C5 PR678-751)), CHIMERIC MONOCLONAL ANTIBODYGAMMA4 HEAVY CHAIN CHIMERIC (1-446) (VH (MUS MUSCULUS IGHV1-61*01 (81.6%)-(IGHD)-IGHJ3*01 (92.9%)/HOMO SAPIENS IGHV1-46*01 (62.2

Common Name

English

Classification Tree Code System Code

FDA ORPHAN DRUG

884822

Created by admin on Sat Dec 16 14:16:59 GMT 2023 , Edited by admin on Sat Dec 16 14:16:59 GMT 2023

Code System Code Type Description

USAN

HI-123

Created by admin on Sat Dec 16 14:16:59 GMT 2023 , Edited by admin on Sat Dec 16 14:16:59 GMT 2023

PRIMARY

SMS_ID

300000021741

Created by admin on Sat Dec 16 14:16:59 GMT 2023 , Edited by admin on Sat Dec 16 14:16:59 GMT 2023

PRIMARY

FDA UNII

F5T0RF9ZJA

Created by admin on Sat Dec 16 14:16:59 GMT 2023 , Edited by admin on Sat Dec 16 14:16:59 GMT 2023

PRIMARY

INN

11304

Created by admin on Sat Dec 16 14:16:59 GMT 2023 , Edited by admin on Sat Dec 16 14:16:59 GMT 2023

PRIMARY

CAS

2250440-41-4

Created by admin on Sat Dec 16 14:16:59 GMT 2023 , Edited by admin on Sat Dec 16 14:16:59 GMT 2023

PRIMARY

CAS

2161337-20-6

Created by admin on Sat Dec 16 14:16:59 GMT 2023 , Edited by admin on Sat Dec 16 14:16:59 GMT 2023

SUPERSEDED

NCI_THESAURUS

C172643

Created by admin on Sat Dec 16 14:16:59 GMT 2023 , Edited by admin on Sat Dec 16 14:16:59 GMT 2023

PRIMARY

ACTIVE MOIETY


					F5T0RF9ZJA